Figures & data
Table 1 Location, Function and Cellular Expression of Sphingosine 1-Phosphate Receptor Subtypes
Table 2 Comparison of Sphingosine 1-Phosphate Receptor Modulators Currently Available for Treating Multiple Sclerosis
Table 3 Main Findings of the Oral Ponesimod versus Teriflunomide in Relapsing Multiple Sclerosis (OPTIMUM)
Table 4 Up-Titration Scheme of Ponesimod to Mitigate the First-Dose Effect on Heart Rate